chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Friday 4/22 @ 2:30 patient was unusable fussy, irritable, and felt warm. She had a fever of 102.7 taken by ear thermometer, no medicine was given. Went to bed at 6:30pm with a fever of 101.6. Saturday 4/23- patient was fussy but seemed not herself all day. Tempature was around 101-102.2 all day. She went to bed  at 6:30 pm with a temp of 101.4. At 10:50pm she woke up screaming and had a temp of 103.6, was given infant MOTRIN for the 1st time in her life. Called the on all Pediatricinan, 40ish minutes later patient vomited the MOTRIN up and we promptly put her in a cool bath to clean her up. At 12:14am her temp was 102.5, she fell asleep around 12:50am. Sunday 4/24- patient had a constant temp of 101 all day. Seemed to be acting more playful but was very tired. Monday 4/25- On patient's forehead a rash started to appear around 3:00pm. By 6:30pm she had red spots on her whole face and some on her upper chest. Tuesday 4/26- 6:00am patient has the red spots all over her face and chest. As the day professed the spots have moved down her body to include her back, top of hands, legs, top of feet. Wednesday 4/27- 6:00am The red spots have somewhat faded on her face, they have turned purple, the red spots have become more red on her chest and she has more that have appeared all over her body. She now has them in her diaper area and on the back of her neck.
Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 28-Jul-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment medications were not reported no concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Non significant follow up. Contact information was updated.
I have been feeling lightheaded and my blood pressure been high for about 2 or 3 weeks.
Pt stated she had a rash within 20 hours after receiving first dose which lasted for two weeks. Pt stated she had to take an oral steroid to  relieve her itching and the rash. Pt stated rash was only on her arms and legs.
sore arm/pain in his left arm when he holds it parallel to the floor; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm/pain in his left arm when he holds it parallel to the floor) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm/pain in his left arm when he holds it parallel to the floor). At the time of the report, PAIN IN EXTREMITY (sore arm/pain in his left arm when he holds it parallel to the floor) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. It was reported that  take Tylenol and Flonase for his symptoms.   This case was linked to MOD-2021-069807, US-MODERNATX, INC.-MOD-2021-069883 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. MOD-2021-069807:Second dose case US-MODERNATX, INC.-MOD-2021-069883:Crosslinked (First dose)
lt thigh abscess w/purulent drainage occurring 1wk p/vax;tx w/PO ATB;
history of coronary artery disease, diabetes, renal failure status post kidney transplant to the emergency department with shortness of breath. He also has a history of heart failure. States he's had a cough and been congested. Admits bilateral lower extremity swelling; patient started with fever  and was tested
pt recvd vax & devel clonic sz; presented to ER; CT scan of head was nl; pt was treated w/Dilantin & sent home; 28APR93 presented to MD; physical & neurological exam were nl x/mild hyperreflexia;
A nurse reported the occurrence of an injection site reaction in an 18-month-old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix).  The medical history, concurrent conditions, and concurrent medications were not provided.  On 06/03/2002, the vaccinee received an injection of Infanrix.  The number of previous injections of Infanrix was not reported.  Sometime after the injection, he developed an injection site reaction characterized by redness, heat, hardness, and a "softball size" area of swelling.  The injection site reaction presisted as of 06/06/2002.  The reporter considered these events to be probably related to Infanrix administration.
Swollen lymph nodes in the left underarm starting 10/9/2021 at 0700 continuing through 10/11/2021
Receive vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Receive vaccine while pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided.   On 26-Dec-2020, the patient experienced EXPOSURE DURING PREGNANCY (Receive vaccine while pregnant). On 26-Dec-2020, EXPOSURE DURING PREGNANCY (Receive vaccine while pregnant) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (had bad pain in her arm) and DIARRHOEA (diarrhea after first dose which relapsed after second dose) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (had bad pain in her arm) and DIARRHOEA (diarrhea after first dose which relapsed after second dose). At the time of the report, PAIN IN EXTREMITY (had bad pain in her arm) outcome was unknown and DIARRHOEA (diarrhea after first dose which relapsed after second dose) had resolved.            No concomitant medications were reported.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Non significant information was received on 31-MAY-2021 contains no new information
Rash/redness/itchiness developed on chest and scalp on 2/27/22. Rash spread throughout upper body. Dermatographia developed on 2/29/22 all over body,  including back, arms, hands, wrists, chest, neck, face. Itchiness seems to subside with prednisone (20mg) and antihistamine cetirizine (Zyrtec) 10mg daily, but dermatographia still present.   Dermatologist visit on 3/8/22 confirmed dermatographia, and advised to take fexofenadine (Allegra) 2x-4x daily for 4 weeks.
Initial report received on 18 October 2007 from a health care professional in the United States. A male patient (demographics unknown), with unknown medical history, had received a right deltoid dose of FLUZONE SV 2007-2008 (lot number U2439AA) ON 16 October 2007. Two hours post-vaccination, the patient developed severe back pain. At the time of this report, the patient's pain was persisting and he was to be evaluated by a physician on 18 October 2007. Treatments received and diagnostic testing performed were not provided. At the time of this report, it was unknown it the patient had recovered.
Client stated that one hour post vaccination whith second Dose of Hep B (Adult dose) she started to have hives on her left arm around the injection site, later the rash went to the other arm, legs and almost all body. Client used OTC hydrocortisone cream and Benadryl; since she still have the hives, client was advice to go to Her private doctor for further treatment.
flu like symptoms and side effects; every joint in her body ached like she couldn't describe; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe) outcome was unknown.            Reporter did not allow further contact
Developed fever Sunday night into Monday along with severe body aches, joints pain and weakness. took Tylenol 500mg every 6 hours. on Tuesday symptoms continued. Wednesday felt little better with no fever but body ache and joint pain continued. Was out from work for 3 days. Weakness and joint pain is still there (today is Saturday). will continue to monitor
Went to Employee Health for MMR shot around 1015, Hives started that evening around 2100.
hot flashes; headache; joint pain; Muscle pain; Fatigue; Pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3247), via an unspecified route of administration in left arm on 17Feb2021 at 15:45 (at 33 years)at single dose for covid-19 immunisation. Medical history included depression and patient was allergic to Dioscorea japonica. No covid prior vaccination. Patient was not covid tested post vaccination. Previously on 28Jan2021 at 13:00 (at 33 years) patient took the first dose of the vaccine (lot EL3247) administered in Left arm for covid-19 immunisation.The patient's concomitant medications were not reported. On 17Feb2021 at 16:15 patient experienced hot flashes, headache, joint pain, muscle pain, fatigue and pain at injection site. No treatment was given and the outcome of all the event was not recovered.Follow-up attempts completed. No further information expected.
About 2 wks after #2 GARDASIL patient began having short, severe headaches N5 min in length x1/wk. H/A progressed to frequency of dly and lasting a full day-pain progressively got more severe to where patient would pass out. Many Dr visits-put on meds-tried several types- ELAVIL, Topiramate. R/O other causes. Dr felt from her vaccination.
A rectangular welt at the site of injection, 1 1/4 x 3 inches that lasted for 5 days.
may have received 0.25 ml for second dose; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (may have received 0.25 ml for second dose) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A and 058H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (may have received 0.25 ml for second dose). On 30-Dec-2021, ACCIDENTAL UNDERDOSE (may have received 0.25 ml for second dose) had resolved.            No concomitant product information was provided. No treatment information was provided.
31MAR96 pt awoke in the morning w/a fever of 103 & was listless;pt returned to sleep @ approx 10:30AM & was sluggish to arouse & was not using lt arm & leg normally;also exp afeb jerks;hosp 1 days w/probable sz disorder;dx Todd's paralysis;
This spontaneous report as received from a Healthcare Worker (certified medical assistant) refers to a patient of unknown age. On 22-FEB-2013 the patient was vaccinated with the first dose of RECOMBIVAX HB (lot# and dose unknown). No other co-suspects were reported. No concomitant medications were reported. On 05-APR-2013, the patient received the second dose of RECOMBIVAX HB, no adverse effect reported. Action taken was not provided. It was unknown if the patient had sought medical attention. The reporter did not provide assessment of the relationship of the adverse event to the suspect therapy. Additional information has been requested.
Pt presents for follow after receiving Men B vaccine on 8/31/22. "A few days" later, pt began to experience a little bit of pain at the site of the injection with associated darkening and a "knot" under the skin. Pt continued to experience pain for about 1 week, when she went to urgent care. UC though the site may have been infected. They prescribed PO Keflex TID x5 days. The abx resolved the pain but the darkened and the underlying knot have persisted, though both are getting a little smaller/lighter. No fevers, no other associated symptoms. This was pt's second dose of the Bexsero vaccine.
broke into a sweat; slightly tired; very low fever; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (slightly tired), PYREXIA (very low fever), TENDERNESS (tenderness  ) and MILIARIA (broke into a sweat) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 023C21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), ACETYLSALICYLIC ACID (BABY ASPIRIN), SOTALOL, LOSARTAN and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 15-Apr-2021, the patient experienced FATIGUE (slightly tired), PYREXIA (very low fever) and TENDERNESS (tenderness  ). On 17-Apr-2021, the patient experienced MILIARIA (broke into a sweat). At the time of the report, FATIGUE (slightly tired), PYREXIA (very low fever), TENDERNESS (tenderness  ) and MILIARIA (broke into a sweat) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-142492 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-142492:crosslinked; wife case
About 12 hours after the vaccination, I developed terrible chills (no fever).  I had to bundle up with lots of clothes and blankets and then continued to shiver while in bed that night.  I also developed incredible fatigue which I am still having 3 days later.  I did not have these symptoms with any of my previous COVID shots - 2 originals and 2 boosters before this.  All of my shots give me soreness at the injection site.
Symptoms began slowly and progressively - numbness in toes and foot drop would begin after walking certain distances. Have been walking with a cane, with muscle weakness. Diagnosed with CIDP and a Multifocal Motor Neuropathy after the presence of Onion Bulbs were found in a nerve biopsy.
Fever 100.8, extreme chills with no relief, large "goose egg" swelling at injection site with excessive sensitivity.
Recurrence of symptoms runny nose, sore throat, congestion; Recurrence of symptoms runny nose, sore throat, congestion; Recurrence of symptoms runny nose, sore throat, congestion; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Recurrence of symptoms runny nose, sore throat, congestion), OROPHARYNGEAL PAIN (Recurrence of symptoms runny nose, sore throat, congestion) and NASAL CONGESTION (Recurrence of symptoms runny nose, sore throat, congestion) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045J21A, 043B21A and 041B21A) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Concurrent medical conditions included Lactose intolerant.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 12-May-2022, the patient experienced RHINORRHOEA (Recurrence of symptoms runny nose, sore throat, congestion), OROPHARYNGEAL PAIN (Recurrence of symptoms runny nose, sore throat, congestion) and NASAL CONGESTION (Recurrence of symptoms runny nose, sore throat, congestion). At the time of the report, RHINORRHOEA (Recurrence of symptoms runny nose, sore throat, congestion), OROPHARYNGEAL PAIN (Recurrence of symptoms runny nose, sore throat, congestion) and NASAL CONGESTION (Recurrence of symptoms runny nose, sore throat, congestion) was resolving. Not Provided          No concomitant medication was reported by reporter.
Weakend legs, fell on 12/31, hospitalized 1/1/2010, Tingling feet, legs and hands 1/5/2010 Diagnosed 1/11/2010 with Guillain-Barre' syndrome treated with immunoglobin 1/12-1/16, plasmapherisis 1/18-still be treated at Hospital.
Patient received flu vaccine at 2:15 PM. Patient was asked if he had received vaccine. He stated "I received the flu vaccine before without any problems." Patient was asked if he has any food or drug allergies and stated no. Patient was advised to stay in clinic area for 15 minutes which he did and left without any complaints. Patient stated "I feel fine." At 3:40 PM patient came back to the clinic area with complaints of muscle achiness in left arm and left leg. Took BP 230/140, retake showed 230/150 and was advised to seek emergency treatment. Patient refused treatment until he called his physician. Emergency Response was called and patient was taken to hospital in ambulance.
Approximately 2 weeks after the 2nd injection bruises and swelling started to appear at multiple lymph nodes. Locations where under arm pits (LH and RH), above and just below LH and RH hips, and groin area. Rough 14+ bruised locations
Recieved flu vaccination around 1500 on 9/26/18. Approximately 1630, patient appeared to be slightly confused with noticeable miosis of both pupils. Eyes appeared red. Patient became lethargic and stated that he was sleepy but could not close his eyes. Axillary temperature at this time was 102.6 degrees Fahrenheit, heart rate 140. Continued to monitor patient. Approximately 1830 axillary temperature reached 103.6. On call physician called. Was directed to monitor patient and administer MOTRIN if patient became uncomfortable. Heart rate at this time 150. MOTRIN administered at 1900. Patient reassessed hourly, at 2130, axillary temperature reached 104 degrees. TYLENOL given at this time. Patient continued to remain febrile until 0200. At 0200 patient temperature 98.6 degrees axillary. Patient reassessed at 0730 am. Patient stated he was excissevely thirsty with no other symptoms.
Bell's Palsy second occurrence. First occurrence 12/18 Numb toes on both feet
headache; tired; temperature of 102; chills, shivering/shaking.; body aches; Initial information received on 08-Oct-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 44 years old male patient who experienced headache (headache), temperature of 102 (Pyrexia), chills, shivering /shaking (Chills), body aches (body pain) and tired (tiredness), while he received vaccine INFLUENZA VACCINE..  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 08-Oct-2019 at 9.00 am, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On 08-Oct-2019, at, 3 pm experienced severe chills and body aches, 6 hours post vacccination. He get into bed at 5:30 pm and could not stop shivering/shaking. At 6:30 pm, 9 hours 30 minutes post vaccination, his temperature 102. Later, he took Tylenol to treat the fever. The severe shivering/shaking went on for several hours. At 11:30 pm his temperature was 100.5.   On 09-Oct-2019, 1 day post vaccination, he was feeling better but his temperature has remained in 99 range, still feeling achy, a headache and generally tired.  (Other relevant tests included No Lab data..)  Final diagnosis was headache, pyrexia, chills, body pain and tiredness.   The patient was treated with PARACETAMOL (TYLENOL) for Pyrexia.  The patient was recovering from events fever and chills. As of 9-Oct-19, patient was not yet recovered from other events.  Information on the batch number was requested.
Patient came back to pharmacy nearly 2 weeks after injection and still had significant bruising and redness at injection site.  No other pain reported.
Immediately after shots were given Pt became unresponsive. Had small seizure lasting only few seconds. We opened airway and laid her flat. She came around quickly no post vital state. Was nauseated, shaky. Call mom and when she got here we called 911. Pt was taken to OSF - EKG labs were done she was released.
15 minutes after receiving vaccine, patient reported itching and one hive near the vaccine site on left arm, also itchiness under his left arm on his rib cage/chest. Patient denied any swelling, SOB, N/V, or any other symptoms. Patient monitored by Allergy, symptoms did not worsen, and allergist communicated pt was ok to leave clinic with outpatient follow-up
Redness/subcutaneous blood below the both eyes down onto both cheeks and near mouth. Similar to periorbital hemorage.